Acquisition Origin Matters: Clinical, Microbiological and Immunological Characteristics and Treatment Effects in Community- vs. Hospital-Acquired Septic Shock
Irene Coloretti(University of Modena and Reggio Emilia), Massimo Girardis(University of Modena and Reggio Emilia), Federica Morselli(Istituti di Ricovero e Cura a Carattere Scientifico), Erica Franceschini(University of Modena and Reggio Emilia), Marianna Meschiari(Azienda Ospedaliero-Universitaria di Modena), Stefano Busani(University of Modena and Reggio Emilia), Emanuela Biagioni(University of Modena and Reggio Emilia), Martina Tosi(University of Modena and Reggio Emilia), Jacopo Bertolini(University of Modena and Reggio Emilia), Elena Munari(University of Modena and Reggio Emilia), Sara Ferrari(University of Modena and Reggio Emilia), Nathan D. Nielsen(University of New Mexico)
Cited by 0
Related Papers
Tocilizumab in patients with severe COVID-19: a retrospective cohort study
|The Lancet Rheumatology|2020|998
Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia
|Nature Communications|2020|846
Seven Versus 14 Days of Antibiotic Therapy for Uncomplicated Gram-negative Bacteremia: A Noninferiority Randomized Controlled Trial
|Clinical Infectious Diseases|2018|424
Hospital-Acquired Infections in Critically Ill Patients With COVID-19
|CHEST Journal|2021|404